U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06950307) titled 'Hypofractionation for Prostate Cancer in Africa: A Feasibility Study' on April 15. Brief Sum... Read More
U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06951607) titled 'Management of Proximal Interphalangeal (PIP) Joint Injuries' on March 18. Brief Summary: Thi... Read More
U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06950671) titled 'Role of Triggering Receptor Expressed on Myeloid Cells (TREM-1) as a Novel Biomarker in Human... Read More
U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06952088) titled 'Face Mask vs Laryngeal Mask in Neonatal Resuscitation' on April 23. Brief Summary: The goal ... Read More
U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06951178) titled 'Long-term Safety and Performance of Materialise's Patient-specific TMJ System.' on April 14. ... Read More
U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06950528) titled 'Monocular-Camera-Based Mobile Exergame for Type 2 Diabetes Prevention' on April 10. Brief Su... Read More
U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06951893) titled 'Identification of Pre-surgical Phenotypic Indicators Predictive of Quality of Life Trajectori... Read More
U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06951698) titled 'A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in B... Read More
U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06951971) titled 'Dose-modified Emapalumab and Ruxolitinib (E-Ru) Regimens for Hemophagocytic Lymphohistiocytos... Read More
U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06951997) titled 'QL1706 Plus Chidamide, AG as First-line Treatment for Metastatic Pancreatic Cancer' on April ... Read More